Hepatitis C in Developing Countries

<p>1. Global Burden of Hepatitis C <br>Section 1.1 The Public Health and Health Care Burden of Hepatitis C Infection <br>Section 1.2 The Economic Burden of Hepatitis C Infection <br>Section 1.3 The Social Burden of Hepatitis C Infection</p> <p>2. The Epidemic of Hepatitis C in Developing Countries<br>Section 2.1 HCV Statistics in Developing Countries<br>Section 2.2 The Growing Challenge of Hepatitis C in Developing Countries<br>Subsection 2.2.a  Epidemiology of Hepatitis C in Developing Countries<br>Subsection 2.2.b  Modes of Transmission of Hepatitis C in Developing Countries<br>Subsection 2.2 c  Socio-political Aspects of Hepatitis C in Developing Countries<br>Subsection 2.2.d. Hepatitis C Genotypes in Developing Countries<br>Subsection 2.2 e. Clinical Patterns and Complications of Hepatitis C Infection in Developing Countries<br>Subsection 2.2.e  Access to Hepatitis C Treatment in Developing Countries <br>Subsection 2.2.f. Impact of Coinfections on Hepatitis C in Developing Countries<br>Section 2.3  Macro and Micro-economics of Hepatitis C in Developing Countries</p> <p>3. The Magnitude of Hepatitis C Problem in Specific Regions <br>Section 3.1 Hepatitis C in Egypt <br>Section 3.2  Hepatitis C in Africa <br>Section 3.3  Hepatitis C in the Middle East <br>Section 3.1 Hepatitis C in Indian Subcontinent <br>Section 3.2  Hepatitis C in Latin America <br>Section 3.3  Hepatitis C in Southeast Asia</p> <p>4. Challenges of Hepatitis C in Developing Countries <br>Section 4.1 Direct Acting Antiviral Agents in Developing Countries <br>Section 4.2 Challenges of Producing Drugs and Potential Vaccines for Hepatitis C Specifically for Developing Countries<br>Section 4.3 Ethics of Hepatitis C Clinical Trials and Research in Developing Countries <br>Section 4.4 Applications of Genetics in Developing Countries <br>Section 4.5 Hepatitis C Surveillance and Prevention in Developing Countries</p>